[18F]氟脱氧葡萄糖PET/CT在评估鼻咽癌PD-L1状态中的价值
本研究回顾性纳入84例初诊鼻咽癌患者,探讨18F-FDG摄取与肿瘤细胞(TCs)及肿瘤浸润免疫细胞(TIICs)PD-L1表达的关系。结果显示TCs中PD-L1表达与SUVmax和TLG正相关,而TIICs中PD-L1表达与SUVmax和血浆EBV载量负相关,提示18F-FDG PET/CT可能有助于评估鼻咽癌患者PD-L1状态。
要点
- 肿瘤细胞PD-L1高表达与SUVmax(P=0.003)和TLG(P=0.001)正相关。
- 肿瘤浸润免疫细胞PD-L1高表达与SUVmax(P=0.038)和血浆EBV载量(P=0.025)负相关。
- 18F-FDG PET/CT可能有助于评估鼻咽癌患者PD-L1状态。
核心结论
- 鼻咽癌病灶18F-FDG摄取与肿瘤细胞PD-L1表达正相关,与肿瘤浸润免疫细胞PD-L1表达负相关。
- 因此18F-FDG PET/CT可能有助于评估鼻咽癌患者PD-L1状态。
研究设计与样本
- 回顾性评估2016年12月至2019年3月间84例初诊鼻咽癌患者的记录,所有组织标本和PET/CT图像均在治疗前采集。
- 肿瘤细胞和肿瘤浸润免疫细胞PD-L1高表达定义为≥50%染色细胞。
主要发现
- 肿瘤细胞和肿瘤浸润免疫细胞的PD-L1状态间18F-FDG摄取存在显著差异。
- 单因素分析显示肿瘤细胞PD-L1表达与SUVmax(P<0.001)、原发肿瘤TLG(P<0.001)和T分期(P=0.044)相关,但与血浆EBV载量无关(P=0.816)。
- 肿瘤浸润免疫细胞PD-L1表达与SUVmax(P=0.011)、TLG(P=0.001)、T分期(P=0.028)和血浆EBV载量(P=0.003)相关。
- 多因素logistic回归中,肿瘤细胞PD-L1表达与SUVmax(P=0.003)和TLG(P=0.001)正相关,肿瘤浸润免疫细胞PD-L1表达与SUVmax(P=0.038)和血浆EBV载量(P=0.025)负相关。
关键数值与推荐
- 肿瘤细胞和肿瘤浸润免疫细胞PD-L1高表达定义为≥50%染色细胞。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To explore the relationship between [18F]fluorodeoxyglucose (18F-FDG uptake) and PD-L1 expression and determine the usefulness of 18F-FDG PET/CT for evaluating the PD-L1 status in tumour cells (TCs) and tumour-infiltrating immune cells (TIICs) in patients with nasopharyngeal carcinoma (NPC). METHODS: We retrospectively evaluated the records of 84 eligible patients who received an initial histopathological diagnosis of NPC between December 2016 and March 2019. All tissue specimens and PET/CT images were collected prior to treatment. High PD-L1 expression in TCs and TIICs was defined as ≥ 50% of stained cells. RESULTS: There was a significant difference in 18F-FDG uptake according to the PD-L1 status in TCs and TIICs. Univariate analysis showed that PD-L1 expression in TCs was associated with tumour maximum standardized uptake value (SUVmax) (P < 0.001), primary tumour total lesion glycolysis (TLG; P < 0.001), and T stage (P = 0.044), but not with plasma Epstein-Barr virus (EBV) load (P = 0.816), whereas PD-L1 expression in TIICs was related to SUVmax (P = 0.011), TLG (P = 0.001), T stage (P = 0.028), and plasma EBV load (P = 0.003). In multivariate logistic regression, PD-L1 expression in TCs was positively associated with SUVmax (P = 0.003) and TLG (P = 0.001), and in TIICs, negatively associated with SUVmax (P = 0.038) and plasma EBV load (P = 0.025). CONCLUSIONS: 18F-FDG uptake in NPC lesions was positively correlated with PD-L1 expression in TCs and negatively correlated with PD-L1 expression in TIICs. Thus, 18F-FDG PET/CT may be useful for evaluating the PD-L1 status in patients with NPC.
引用
- Zhao L, Zhuang Y, Fu K, et al. Usefulness of [18F]fluorodeoxyglucose PET/CT for evaluating the PD-L1 status in nasopharyngeal carcinoma. Eur J Nucl Med Mol Imaging. 2020. PMID: 31897588. doi:10.1007/s00259-019-04654-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。